ANAYA KOLE: Open Payments
NPI 1063066637 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,229 in 33 payments from 16 companies in 2025. Trend: 2023 $1,080 · 2024 $1,432 · 2025 $3,229
Food & beverage: $3,229
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $382 |
| Amgen Inc. | 3 | $346 |
| Axsome Therapeutics, Inc. | 3 | $343 |
| Otsuka America Pharmaceutical, Inc. | 4 | $326 |
| E.R. Squibb & Sons, L.L.C. | 2 | $256 |
| Tris Pharma Inc | 2 | $243 |
| Novo Nordisk Inc | 2 | $228 |
| ABBVIE INC. | 3 | $172 |
| Lundbeck LLC | 4 | $170 |
| AstraZeneca Pharmaceuticals LP | 1 | $127 |
Products named: REXULTI, UZEDY, COBENFY, Dyanavel XR, Auvelity, VRAYLAR, TEZSPIRE, WAINUA.
Industry payments across KS — which companies pay providers there.
